These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 18422780

  • 1. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG, Velloso-Rodrigues C, Moreau V, Nguyen C, Villard S, Belisário AR, Granier C, Santoro MM.
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [Abstract] [Full Text] [Related]

  • 2. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S, Sharifian RA, Khoshnoodi J, Karimi K, Milani M, Okita DK, Shokri F, Conti-Fine BM.
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides.
    Di Giambattista M, Branckaert T, Laub R.
    Biologicals; 2001 May; 29(3-4):229-32. PubMed ID: 11851320
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
    Lebreton A, Moreau V, Lapalud P, Cayzac C, André S, Nguyen C, Schved JF, Lavigne G, Granier C.
    Br J Haematol; 2011 Nov; 155(4):487-97. PubMed ID: 21933172
    [Abstract] [Full Text] [Related]

  • 7. Role of anti-idiotypic antibodies in immune tolerance induction.
    Gilles JG.
    Haemophilia; 2010 May; 16(102):80-3. PubMed ID: 20536989
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S, Ghods R, Bahrami ZS, Roohi A, Jeddi-Tehrani M, Conti-Fine BM, Sharifian RA, Rabbani H, Shokri F.
    Hum Antibodies; 2003 May; 12(3):67-76. PubMed ID: 14646035
    [Abstract] [Full Text] [Related]

  • 10. Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII.
    Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A.
    Thromb Haemost; 2005 Nov; 94(5):933-41. PubMed ID: 16363233
    [Abstract] [Full Text] [Related]

  • 11. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
    Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A.
    J Immunol Methods; 2006 Jan 20; 308(1-2):90-100. PubMed ID: 16376372
    [Abstract] [Full Text] [Related]

  • 12. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients.
    Blanco AN, Peirano AA, Grosso SH, Gennari LC, Bianco RP, Lazzari MA.
    Haematologica; 2000 Oct 20; 85(10):1045-50. PubMed ID: 11025595
    [Abstract] [Full Text] [Related]

  • 13. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
    Suzuki H, Shima M, Arai M, Kagawa K, Fukutake K, Kamisue S, Nakai H, Morichika S, Tanaka I, Inoue M, Gale K, Tuddenham EG, Yoshioka A.
    Thromb Haemost; 1997 May 20; 77(5):862-7. PubMed ID: 9184393
    [Abstract] [Full Text] [Related]

  • 14. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F, Gharagozlou S, Sharifian RA, Kazemnejad A, Esmailzadeh K, Managhchi MR, Shokri F.
    Acta Haematol; 2005 May 20; 114(2):84-90. PubMed ID: 16103630
    [Abstract] [Full Text] [Related]

  • 15. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor.
    Foster PA, Fulcher CA, Houghten RA, Zimmerman TS.
    Thromb Haemost; 1990 Jun 28; 63(3):403-6. PubMed ID: 2119526
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous detection and epitope mapping of anti-factor VIII antibodies.
    Lavigne-Lissalde G, Tarrade C, Lapalud P, Chtourou S, Schved JF, Granier C, Villard-Saussine S.
    Thromb Haemost; 2008 Jun 28; 99(6):1090-6. PubMed ID: 18521513
    [Abstract] [Full Text] [Related]

  • 17. F VIII subunits: purification and antigenic properties.
    Nordfang O, Ezban M, Hansen JJ.
    Thromb Haemost; 1987 Dec 18; 58(4):1043-8. PubMed ID: 3127917
    [Abstract] [Full Text] [Related]

  • 18. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor.
    Sugihara T, Takahashi I, Kojima T, Okamoto Y, Yamamoto K, Kamiya T, Matsushita T, Saito H.
    Nagoya J Med Sci; 2000 May 18; 63(1-2):25-39. PubMed ID: 10911718
    [Abstract] [Full Text] [Related]

  • 19. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
    Nogami K, Shima M, Nishiya K, Sakurai Y, Tanaka I, Giddings JC, Saenko EL, Yoshioka A.
    Thromb Haemost; 2002 Mar 18; 87(3):459-65. PubMed ID: 11916079
    [Abstract] [Full Text] [Related]

  • 20. Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain.
    Laub R, Di Giambattista M, Fondu P, Brackmann HH, Lenk H, Saenko EL, Felch M, Scandella D.
    Thromb Haemost; 1999 Jan 18; 81(1):39-44. PubMed ID: 9974372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.